Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 1 to 20 of 165

    1.

    Acute myeloid leukemia: 2013 update on risk-stratification and management.

    Estey EH.

    Am J Hematol. 2013 Apr;88(4):318-27. doi: 10.1002/ajh.23404. Review.

    PMID:
    23526416
    [PubMed - indexed for MEDLINE]
    2.

    Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.

    Walter RB, Othus M, Burnett AK, Löwenberg B, Kantarjian HM, Ossenkoppele GJ, Hills RK, van Montfort KG, Ravandi F, Evans A, Pierce SR, Appelbaum FR, Estey EH.

    Blood. 2013 Mar 28;121(13):2424-31. doi: 10.1182/blood-2012-10-462440. Epub 2013 Jan 16.

    PMID:
    23325837
    [PubMed - indexed for MEDLINE]
    3.

    Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.

    Thol F, Winschel C, Sonntag AK, Damm F, Wagner K, Chaturvedi A, Göhring G, Schlegelberger B, Lübbert M, Fiedler W, Kirchner H, Krauter J, Ganser A, Heuser M.

    Ann Hematol. 2013 Mar;92(3):315-23. doi: 10.1007/s00277-012-1637-5. Epub 2012 Dec 12.

    PMID:
    23233047
    [PubMed - indexed for MEDLINE]
    4.

    C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia.

    Alberich-Jordà M, Wouters B, Balastik M, Shapiro-Koss C, Zhang H, Di Ruscio A, Radomska HS, Ebralidze AK, Amabile G, Ye M, Zhang J, Lowers I, Avellino R, Melnick A, Figueroa ME, Valk PJ, Delwel R, Tenen DG.

    J Clin Invest. 2012 Dec 3;122(12):4490-504. doi: 10.1172/JCI65102. Epub 2012 Nov 19. Erratum in: J Clin Invest. 2013 Jan 2;123(1):526. DiRuscio, Annalisa [corrected to Di Ruscio, Annalisa].

    PMID:
    23160200
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.

    Hickey CJ, Schwind S, Radomska HS, Dorrance AM, Santhanam R, Mishra A, Wu YZ, Alachkar H, Maharry K, Nicolet D, Mrózek K, Walker A, Eiring AM, Whitman SP, Becker H, Perrotti D, Wu LC, Zhao X, Fehniger TA, Vij R, Byrd JC, Blum W, Lee LJ, Caligiuri MA, Bloomfield CD, Garzon R, Marcucci G.

    Blood. 2013 Jan 3;121(1):159-69. doi: 10.1182/blood-2012-05-428573. Epub 2012 Oct 25.

    PMID:
    23100311
    [PubMed - indexed for MEDLINE]
    6.

    Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

    Mrózek K, Marcucci G, Nicolet D, Maharry KS, Becker H, Whitman SP, Metzeler KH, Schwind S, Wu YZ, Kohlschmidt J, Pettenati MJ, Heerema NA, Block AW, Patil SR, Baer MR, Kolitz JE, Moore JO, Carroll AJ, Stone RM, Larson RA, Bloomfield CD.

    J Clin Oncol. 2012 Dec 20;30(36):4515-23. doi: 10.1200/JCO.2012.43.4738. Epub 2012 Sep 17.

    PMID:
    22987078
    [PubMed - indexed for MEDLINE]
    7.

    Rapid screening of ASXL1, IDH1, IDH2, and c-CBL mutations in de novo acute myeloid leukemia by high-resolution melting.

    Ibáñez M, Such E, Cervera J, Luna I, Gómez-Seguí I, López-Pavía M, Dolz S, Barragán E, Fuster O, Llop M, Rodríguez-Veiga R, Avaria A, Oltra S, Senent ML, Moscardó F, Montesinos P, Martínez-Cuadrón D, Martín G, Sanz MA.

    J Mol Diagn. 2012 Nov;14(6):594-601. doi: 10.1016/j.jmoldx.2012.06.006. Epub 2012 Aug 25. Erratum in: J Mol Diagn. 2013 Mar;15(2):280.

    PMID:
    22929312
    [PubMed - indexed for MEDLINE]
    8.

    The prognostic value of CXCR4 in acute myeloid leukemia.

    Ahn JY, Seo K, Weinberg OK, Arber DA.

    Appl Immunohistochem Mol Morphol. 2013 Jan;21(1):79-84. doi: 10.1097/PAI.0b013e3182606f4d.

    PMID:
    22914607
    [PubMed - indexed for MEDLINE]
    9.

    Myeloid malignancies: mutations, models and management.

    Murati A, Brecqueville M, Devillier R, Mozziconacci MJ, Gelsi-Boyer V, Birnbaum D.

    BMC Cancer. 2012 Jul 23;12:304. doi: 10.1186/1471-2407-12-304. Review.

    PMID:
    22823977
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures.

    Mendler JH, Maharry K, Radmacher MD, Mrózek K, Becker H, Metzeler KH, Schwind S, Whitman SP, Khalife J, Kohlschmidt J, Nicolet D, Powell BL, Carter TH, Wetzler M, Moore JO, Kolitz JE, Baer MR, Carroll AJ, Larson RA, Caligiuri MA, Marcucci G, Bloomfield CD.

    J Clin Oncol. 2012 Sep 1;30(25):3109-18. doi: 10.1200/JCO.2011.40.6652. Epub 2012 Jul 2.

    PMID:
    22753902
    [PubMed - indexed for MEDLINE]
    11.

    Molecular evaluation of CEBPA gene mutation in normal karyotype acute myeloid leukemia: a comparison of two methods and report of novel CEBPA mutations from Indian acute myeloid leukemia patients.

    Ahmad F, Rajput S, Mandava S, Das BR.

    Genet Test Mol Biomarkers. 2012 Jul;16(7):707-15. doi: 10.1089/gtmb.2011.0317. Epub 2012 Jun 25.

    PMID:
    22731647
    [PubMed - indexed for MEDLINE]
    12.

    Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.

    Dunlap J, Beadling C, Warrick A, Neff T, Fleming WH, Loriaux M, Heinrich MC, Kovacsovics T, Kelemen K, Leeborg N, Gatter K, Braziel RM, Press R, Corless CL, Fan G.

    Hum Pathol. 2012 Dec;43(12):2167-76. doi: 10.1016/j.humpath.2012.03.002. Epub 2012 Jun 1.

    PMID:
    22658276
    [PubMed - indexed for MEDLINE]
    13.

    GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.

    Greif PA, Dufour A, Konstandin NP, Ksienzyk B, Zellmeier E, Tizazu B, Sturm J, Benthaus T, Herold T, Yaghmaie M, Dörge P, Hopfner KP, Hauser A, Graf A, Krebs S, Blum H, Kakadia PM, Schneider S, Hoster E, Schneider F, Stanulla M, Braess J, Sauerland MC, Berdel WE, Büchner T, Woermann BJ, Hiddemann W, Spiekermann K, Bohlander SK.

    Blood. 2012 Jul 12;120(2):395-403. doi: 10.1182/blood-2012-01-403220. Epub 2012 May 30.

    PMID:
    22649106
    [PubMed - indexed for MEDLINE]
    14.

    Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.

    Guo H, Ma O, Speck NA, Friedman AD.

    Blood. 2012 May 10;119(19):4408-18. doi: 10.1182/blood-2011-12-397091. Epub 2012 Mar 26.

    PMID:
    22451420
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.

    Bacher U, Schnittger S, Macijewski K, Grossmann V, Kohlmann A, Alpermann T, Kowarsch A, Nadarajah N, Kern W, Haferlach C, Haferlach T.

    Blood. 2012 May 17;119(20):4719-22. doi: 10.1182/blood-2011-12-395574. Epub 2012 Mar 22.

    PMID:
    22442349
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

    Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J, Van Vlierberghe P, Dolgalev I, Thomas S, Aminova O, Huberman K, Cheng J, Viale A, Socci ND, Heguy A, Cherry A, Vance G, Higgins RR, Ketterling RP, Gallagher RE, Litzow M, van den Brink MR, Lazarus HM, Rowe JM, Luger S, Ferrando A, Paietta E, Tallman MS, Melnick A, Abdel-Wahab O, Levine RL.

    N Engl J Med. 2012 Mar 22;366(12):1079-89. doi: 10.1056/NEJMoa1112304. Epub 2012 Mar 14.

    PMID:
    22417203
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Novel mutations in CEBPA in Korean Patients with acute myeloid leukemia with a normal karyotype.

    Kim S, Kim DH, Jang JH, Jung CW, Jang MA, Ki CS, Kim JW, Kim SH, Kim HJ.

    Ann Lab Med. 2012 Mar;32(2):153-7. doi: 10.3343/alm.2012.32.2.153. Epub 2012 Feb 23.

    PMID:
    22389883
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis.

    Quintana-Bustamante O, Lan-Lan Smith S, Griessinger E, Reyal Y, Vargaftig J, Lister TA, Fitzgibbon J, Bonnet D.

    Leukemia. 2012 Jul;26(7):1537-46. doi: 10.1038/leu.2012.38. Epub 2012 Feb 10.

    PMID:
    22371011
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients.

    Dufour A, Schneider F, Hoster E, Benthaus T, Ksienzyk B, Schneider S, Kakadia PM, Sauerland MC, Berdel WE, Büchner T, Wörmann B, Braess J, Subklewe M, Hiddemann W, Bohlander SK, Spiekermann K; AML CG study group.

    Ann Hematol. 2012 Jul;91(7):1051-63. doi: 10.1007/s00277-012-1423-4. Epub 2012 Feb 24.

    PMID:
    22362118
    [PubMed - indexed for MEDLINE]
    20.

    Molecular and clinicopathologic characterization of AML with isolated trisomy 4.

    Bains A, Lu G, Yao H, Luthra R, Medeiros LJ, Sargent RL.

    Am J Clin Pathol. 2012 Mar;137(3):387-94. doi: 10.1309/AJCP7ZC9YQERSKGX.

    PMID:
    22338050
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk